The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2015
Filed:
Jul. 21, 2014
Applicants:
Khalid A. El Sayed, West Monroe, LA (US);
Paul W. Sylvester, West Monroe, LA (US);
Fathy A. Behery, Riyadh, SA;
Inventors:
Khalid A. El Sayed, West Monroe, LA (US);
Paul W. Sylvester, West Monroe, LA (US);
Fathy A. Behery, Riyadh, SA;
Assignee:
FIRST TECH INTERNATIONAL LIMITED, Beijing, CN;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/16 (2006.01); A61K 31/35 (2006.01); C07D 498/04 (2006.01); C07D 311/72 (2006.01); C07D 311/70 (2006.01);
U.S. Cl.
CPC ...
C07D 498/04 (2013.01); C07D 311/70 (2013.01); C07D 311/72 (2013.01);
Abstract
Compositions of matter including (R)-2,5,6,8-tetramethyl-8-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)-1,2,3,8,9,10-hexahydrochromeno[5,6-e][1,3]oxazine and (R)-2,6,8-trimethyl-8-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)-1,2,3,8,9,10-hexahydrochromeno[5,6-e][1,3]oxazine are disclosed herein. Further disclosed are methods of preparation of such compounds and the use of such compounds as anticancer agents.